Table 3.
Concurrent medication | Number of cats (group A) | Number of cats (group B) | Number of cats (group C) | Number of cats (group D) |
---|---|---|---|---|
| ||||
Glucosamines * | 9 | 8 | 5 | 1 |
Pentosan polysulphate * | 9 | 8 | 3 | 1 |
Neomercazole/I131 † | 4/2 | 5/1 | 4/0 | 6/0 |
Amlodipine ‡ | 8 | 3 | 10 | 0 |
Tramadol | 2 | 1 | 0 | 0 |
Cisapride | 2 | 0 | 2 | 0 |
Insulin glargine | 2 | 0 | 0 | 1 |
Phenobarbitone | 1 | 0 | 1 | 0 |
Cobalamine | 1 | 0 | 0 | 0 |
Benazepril | 1 ‖ | 0 | 1 § | 3 § |
Famciclovir | 0 | 0 | 1 | 0 |
Prednisolone | 0 | 0 | 2 | 5 |
Potassium gluconate | 0 | 0 | 2 | 0 |
No concurrent medication | 3 | 1 | 5 | 3 |
Chlorambucil | 0 | 0 | 0 | 2 |
Frusemide | 0 | 0 | 0 | 2 |
Treatment for DJD.
Treatment for hyperthyroidism.
Treatment for hypertension. One cat in group A had untreated hypertension.
For renal hypertension or congestive heart failure.
Benazepril treated cat for heart failure from a cardiomyopathy.